Related Experiment Videos
A case of advanced esophageal cancer showing a long-term complete response with chemotherapy with nedaplatin alone
T Satoh1, K Tsushima, S Saitoh
1First Department of Internal Medicine, Hirosaki University School of Medicine, Aomori, Japan. tsatoh-hki@umin.u-tokyo.ac.jp
Abstract:
We describe a case of advanced esophageal cancer treated successfully by chemotherapy with nedaplatin alone. A 60-year-old male with type 2 advanced esophageal cancer, which was located in the upper part of the esophagus and had invaded adjacent organs, was treated with nedaplatin 150 mg/body (100 mg/m2) given intravenously every 4 weeks from January 6, 1991. He achieved a partial response (PR) and was discharged in March 1991. Subsequently, he received nedaplatin 75 mg/body in an out-patient setting almost every month until August 1992. Toxicities were tolerable and included mild thrombocytopenia and nausea/vomiting. From serial evaluation in October 1993, the esophageal tumor was not observed. After 7 years since initial chemotherapy was administered, he still survives without the disease.